Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Neoadjuvant Systemic Therapy and Nodal Management in cT1-2 N0 Triple-Negative Breast Cancer

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Masuda N, Lee SJ, Ohtani S, et al. Adjuvant capecitabine for breast cancer after preoperative chemotherapy. N Engl J Med. 2017;376(22):2147–59. https://doi.org/10.1056/NEJMoa1612645.

    Article  CAS  PubMed  Google Scholar 

  2. Rogers C, Cobb AN, Lloren JIC, et al. National trends in neoadjuvant chemotherapy utilization in patients with early-stage node-negative triple-negative breast cancer: the impact of the CREATE-X trial. Breast Cancer Res Treat. 2024;203(2):317–28. https://doi.org/10.1007/s10549-023-07114-8.

    Article  CAS  PubMed  Google Scholar 

  3. Cortina CS, Lloren JIC, Rogers C, et al. Does neoadjuvant chemotherapy in clinical T1–T2 N0 triple-negative breast cancer increase the extent of axillary surgery? Ann Surg Oncol. Epub 25 Jan 2024. https://doi.org/10.1245/s10434-024-14914-9

  4. Schmid P, Cortes J, Pusztai L, et al. Pembrolizumab for early triple-negative breast cancer. N Engl J Med. 2020;382(9):810–21. https://doi.org/10.1056/NEJMoa1910549.

    Article  CAS  PubMed  Google Scholar 

  5. Khan TM, Rossi AJ, Suman V, Haffty B, Hernandez JM, Boughey JC. Is axillary radiation not inferior to axillary dissection for sentinel lymph node-positive breast cancer after neoadjuvant chemotherapy? Ann Surg Oncol. 2022;29(3):1526–7. https://doi.org/10.1245/s10434-021-10830-4.

    Article  PubMed  Google Scholar 

Download references

Funding

CSC is supported by the National Institutes of Health (NIH) under award number 1K08CA276706-01A1 (Principal Investigator: CSC). The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.

Author information

Authors and Affiliations

  1. Division of Surgical Oncology, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA

    Chandler S. Cortina MD, MS, FSSO, FACS & Christine C. Rogers BS

  2. Medical College of Wisconsin Cancer Center, Milwaukee, WI, USA

    Chandler S. Cortina MD, MS, FSSO, FACS

  3. Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Mediget Teshome MD, MPH, FSSO, FACS

Authors
  1. Chandler S. Cortina MD, MS, FSSO, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christine C. Rogers BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mediget Teshome MD, MPH, FSSO, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chandler S. Cortina MD, MS, FSSO, FACS.

Ethics declarations

Disclosure

Mediget Teshome reports conference travel and accommodations from Endomag Ltd (not relevant to this work). Chandler S. Cortina and Christine C. Rogers have no conflicts of interest to declare in relation to this work.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article refers to: Cortina CS, Lloren JIC, Rogers C, et al. Does Neoadjuvant Chemotherapy in Clinical T1–T2 N0 Triple-Negative Breast Cancer Increase the Extent of Axillary Surgery? Annals Surgical Oncology. Epub 25 Jan 2024. https://doi.org/10.1245/s10434-024-14914-9.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cortina, C.S., Rogers, C.C. & Teshome, M. ASO Author Reflections: Neoadjuvant Systemic Therapy and Nodal Management in cT1-2 N0 Triple-Negative Breast Cancer. Ann Surg Oncol 31, 3196–3197 (2024). https://doi.org/10.1245/s10434-024-15020-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-024-15020-6

Search

Navigation